CN103933282B - 一种治疗糖尿病的中药胶囊 - Google Patents
一种治疗糖尿病的中药胶囊 Download PDFInfo
- Publication number
- CN103933282B CN103933282B CN201310019988.1A CN201310019988A CN103933282B CN 103933282 B CN103933282 B CN 103933282B CN 201310019988 A CN201310019988 A CN 201310019988A CN 103933282 B CN103933282 B CN 103933282B
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- blood
- dragon
- diabetes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 49
- 239000002775 capsule Substances 0.000 title claims abstract description 18
- 239000003814 drug Substances 0.000 claims abstract description 63
- 239000008280 blood Substances 0.000 claims abstract description 45
- 210000004369 blood Anatomy 0.000 claims abstract description 45
- 239000009136 dragon's blood Substances 0.000 claims abstract description 42
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 31
- 240000004824 Trimezia steyermarkii Species 0.000 claims abstract description 30
- 241000132012 Atractylodes Species 0.000 claims abstract description 29
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 28
- 235000008434 ginseng Nutrition 0.000 claims abstract description 28
- 239000009636 Huang Qi Substances 0.000 claims abstract description 27
- 240000000249 Morus alba Species 0.000 claims abstract description 27
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 27
- 239000000843 powder Substances 0.000 claims abstract description 26
- 235000019640 taste Nutrition 0.000 claims abstract description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 20
- 239000000284 extract Substances 0.000 claims abstract description 15
- 208000024891 symptom Diseases 0.000 claims abstract description 11
- 229920001353 Dextrin Polymers 0.000 claims abstract description 8
- 239000004375 Dextrin Substances 0.000 claims abstract description 8
- 235000019425 dextrin Nutrition 0.000 claims abstract description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 6
- 239000008103 glucose Substances 0.000 claims abstract description 6
- 239000004480 active ingredient Substances 0.000 claims abstract description 4
- 238000002386 leaching Methods 0.000 claims abstract 3
- 241000208340 Araliaceae Species 0.000 claims description 27
- 239000006071 cream Substances 0.000 claims description 5
- 239000002245 particle Substances 0.000 claims description 3
- -1 is well mixed Substances 0.000 claims description 2
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims 1
- 235000017491 Bambusa tulda Nutrition 0.000 claims 1
- 244000082204 Phyllostachys viridis Species 0.000 claims 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims 1
- 239000011425 bamboo Substances 0.000 claims 1
- 239000010977 jade Substances 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 22
- 239000000463 material Substances 0.000 abstract description 22
- 201000010099 disease Diseases 0.000 abstract description 21
- 210000004072 lung Anatomy 0.000 abstract description 20
- 238000002360 preparation method Methods 0.000 abstract description 18
- 239000006187 pill Substances 0.000 abstract description 17
- 210000002784 stomach Anatomy 0.000 abstract description 17
- 230000007812 deficiency Effects 0.000 abstract description 15
- 238000011282 treatment Methods 0.000 abstract description 14
- 239000008187 granular material Substances 0.000 abstract description 11
- 239000007787 solid Substances 0.000 abstract description 9
- 239000003795 chemical substances by application Substances 0.000 abstract description 7
- 208000031975 Yang Deficiency Diseases 0.000 abstract description 6
- 240000005373 Panax quinquefolius Species 0.000 abstract description 4
- 238000010792 warming Methods 0.000 abstract description 3
- 239000003390 Chinese drug Substances 0.000 abstract 1
- 239000006286 aqueous extract Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 description 27
- 239000000203 mixture Substances 0.000 description 18
- 235000009508 confectionery Nutrition 0.000 description 17
- 230000000694 effects Effects 0.000 description 16
- 230000001737 promoting effect Effects 0.000 description 16
- 239000000047 product Substances 0.000 description 13
- 238000005516 engineering process Methods 0.000 description 12
- 230000017531 blood circulation Effects 0.000 description 11
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Substances N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 11
- 210000000952 spleen Anatomy 0.000 description 11
- 208000004880 Polyuria Diseases 0.000 description 10
- 238000001035 drying Methods 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- 230000001114 myogenic effect Effects 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 230000035922 thirst Effects 0.000 description 10
- 230000035619 diuresis Effects 0.000 description 9
- 239000000706 filtrate Substances 0.000 description 9
- 239000000796 flavoring agent Substances 0.000 description 9
- 235000019634 flavors Nutrition 0.000 description 9
- 235000013305 food Nutrition 0.000 description 9
- 230000006870 function Effects 0.000 description 8
- 206010012735 Diarrhoea Diseases 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 6
- 102000004877 Insulin Human genes 0.000 description 6
- 108090001061 Insulin Proteins 0.000 description 6
- 210000001124 body fluid Anatomy 0.000 description 6
- 239000010839 body fluid Substances 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 229940125396 insulin Drugs 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 238000010791 quenching Methods 0.000 description 6
- 210000002105 tongue Anatomy 0.000 description 6
- 206010030113 Oedema Diseases 0.000 description 5
- 206010040943 Skin Ulcer Diseases 0.000 description 5
- 244000269722 Thea sinensis Species 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 210000001015 abdomen Anatomy 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 229930003935 flavonoid Natural products 0.000 description 5
- 150000002215 flavonoids Chemical class 0.000 description 5
- 235000017173 flavonoids Nutrition 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- 150000004676 glycans Chemical class 0.000 description 5
- 238000005469 granulation Methods 0.000 description 5
- 230000003179 granulation Effects 0.000 description 5
- 201000001421 hyperglycemia Diseases 0.000 description 5
- 230000001939 inductive effect Effects 0.000 description 5
- 230000033001 locomotion Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 230000036407 pain Effects 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- 239000005017 polysaccharide Substances 0.000 description 5
- 210000002700 urine Anatomy 0.000 description 5
- 241001061264 Astragalus Species 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- 208000002249 Diabetes Complications Diseases 0.000 description 4
- 206010012655 Diabetic complications Diseases 0.000 description 4
- 235000006533 astragalus Nutrition 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 229930182478 glucoside Natural products 0.000 description 4
- 241000411851 herbal medicine Species 0.000 description 4
- 235000008216 herbs Nutrition 0.000 description 4
- 230000002218 hypoglycaemic effect Effects 0.000 description 4
- 230000001077 hypotensive effect Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 230000027939 micturition Effects 0.000 description 4
- 210000004233 talus Anatomy 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 239000011573 trace mineral Substances 0.000 description 4
- 235000013619 trace mineral Nutrition 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 235000002789 Panax ginseng Nutrition 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 150000008131 glucosides Chemical class 0.000 description 3
- 235000013402 health food Nutrition 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 210000003127 knee Anatomy 0.000 description 3
- 239000003973 paint Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 235000021251 pulses Nutrition 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 239000011122 softwood Substances 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 150000008130 triterpenoid saponins Chemical class 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- 241000427159 Achyranthes Species 0.000 description 2
- 229940077274 Alpha glucosidase inhibitor Drugs 0.000 description 2
- 229940123208 Biguanide Drugs 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 241001306121 Dracaena <Squamata> Species 0.000 description 2
- 206010013911 Dysgeusia Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- AFOKZNPZDXHDHD-UHFFFAOYSA-N Morusinol Chemical compound O1C2=C3C=CC(C)(C)OC3=CC(O)=C2C(=O)C(CCC(C)(O)C)=C1C1=CC=C(O)C=C1O AFOKZNPZDXHDHD-UHFFFAOYSA-N 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000003888 alpha glucosidase inhibitor Substances 0.000 description 2
- 239000003472 antidiabetic agent Substances 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 235000015111 chews Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 208000004104 gestational diabetes Diseases 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 235000021374 legumes Nutrition 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 206010036067 polydipsia Diseases 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000010415 tropism Effects 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 208000019206 urinary tract infection Diseases 0.000 description 2
- UGJAEDFOKNAMQD-DVQDXYAYSA-N (-)-Falcarinol Natural products CCCCCCC\C=C\CC#CC#C[C@@H](O)C=C UGJAEDFOKNAMQD-DVQDXYAYSA-N 0.000 description 1
- JQNVCUBPURTQPQ-UHFFFAOYSA-N (25R)-Inokosterone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C)(O)C(O)CCC(CO)C)CCC33O)C)C3=CC(=O)C21 JQNVCUBPURTQPQ-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- UGJAEDFOKNAMQD-MQNTZWLQSA-N (3S,9Z)-1,9-Heptadecadiene-4,6-diyn-3-ol Chemical compound CCCCCCC\C=C/CC#CC#C[C@@H](O)C=C UGJAEDFOKNAMQD-MQNTZWLQSA-N 0.000 description 1
- OGYGFUAIIOPWQD-UHFFFAOYSA-N 1,3-thiazolidine Chemical compound C1CSCN1 OGYGFUAIIOPWQD-UHFFFAOYSA-N 0.000 description 1
- CFNMUZCFSDMZPQ-GHXNOFRVSA-N 7-[(z)-3-methyl-4-(4-methyl-5-oxo-2h-furan-2-yl)but-2-enoxy]chromen-2-one Chemical compound C=1C=C2C=CC(=O)OC2=CC=1OC/C=C(/C)CC1OC(=O)C(C)=C1 CFNMUZCFSDMZPQ-GHXNOFRVSA-N 0.000 description 1
- 241000746976 Agavaceae Species 0.000 description 1
- 240000001592 Amaranthus caudatus Species 0.000 description 1
- 235000009328 Amaranthus caudatus Nutrition 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 241000092665 Atractylodes macrocephala Species 0.000 description 1
- TYPSVDGIQAOBAD-DZGCQCFKSA-N Atractylone Chemical compound C([C@]1(C)C2)CCC(=C)[C@@H]1CC1=C2OC=C1C TYPSVDGIQAOBAD-DZGCQCFKSA-N 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical compound NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 description 1
- 241000283725 Bos Species 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- SXAMSIHRCZWLMU-UHFFFAOYSA-N Convallamarin Natural products CC1OC(OC2C(C)OC(OC3CC(CC4CCC5C(CCC6(C)C5CC7OC(O)(CCC(=C)COC8OC(CO)C(O)C(O)C8O)C(C)C67)C34C)OC9OC(CO)C(OC%10OC(C)C(O)C(O)C%10O)C(O)C9O)C(O)C2O)C(O)C(O)C1O SXAMSIHRCZWLMU-UHFFFAOYSA-N 0.000 description 1
- 241000186227 Corynebacterium diphtheriae Species 0.000 description 1
- PQMOXTJVIYEOQL-UHFFFAOYSA-N Cumarin Natural products CC(C)=CCC1=C(O)C(C(=O)C(C)CC)=C(O)C2=C1OC(=O)C=C2CCC PQMOXTJVIYEOQL-UHFFFAOYSA-N 0.000 description 1
- 241001269238 Data Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- 208000002230 Diabetic coma Diseases 0.000 description 1
- 241001448411 Dracaena draco Species 0.000 description 1
- FWKBXSPDFCAHFN-UHFFFAOYSA-N Dracorubin Natural products C1CC=2C(OC)=CC=3OC(C=45)=C(C)C(=O)C=C5OC(C=5C=CC=CC=5)=CC=4C=3C=2OC1C1=CC=CC=C1 FWKBXSPDFCAHFN-UHFFFAOYSA-N 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- UGJAEDFOKNAMQD-UHFFFAOYSA-N Falcarinol Natural products CCCCCCCC=CCC#CC#CC(O)C=C UGJAEDFOKNAMQD-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 206010018473 Glycosuria Diseases 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 208000025309 Hair disease Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- JQNVCUBPURTQPQ-FTWMDKANSA-N Inokosterone Natural products O=C1[C@H]2[C@@](C)([C@@H]3C([C@@]4(O)[C@@](C)([C@H]([C@@](O)([C@@H](O)CC[C@H](CO)C)C)CC4)CC3)=C1)C[C@H](O)[C@H](O)C2 JQNVCUBPURTQPQ-FTWMDKANSA-N 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 229940122199 Insulin secretagogue Drugs 0.000 description 1
- 229940122355 Insulin sensitizer Drugs 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- FSOGIJPGPZWNGO-UHFFFAOYSA-N Meomammein Natural products CCC(C)C(=O)C1=C(O)C(CC=C(C)C)=C(O)C2=C1OC(=O)C=C2CCC FSOGIJPGPZWNGO-UHFFFAOYSA-N 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 102000052651 Pancreatic hormone Human genes 0.000 description 1
- 101800001268 Pancreatic hormone Proteins 0.000 description 1
- 241000282376 Panthera tigris Species 0.000 description 1
- 241001633680 Polygonatum odoratum Species 0.000 description 1
- JMFSHKGXVSAJFY-UHFFFAOYSA-N Saponaretin Natural products OCC(O)C1OC(Oc2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C1O JMFSHKGXVSAJFY-UHFFFAOYSA-N 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 206010058679 Skin oedema Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical class O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 102100026383 Vasopressin-neurophysin 2-copeptin Human genes 0.000 description 1
- MOZJVOCOKZLBQB-UHFFFAOYSA-N Vitexin Natural products OCC1OC(Oc2c(O)c(O)cc3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C(O)C1O MOZJVOCOKZLBQB-UHFFFAOYSA-N 0.000 description 1
- 206010051373 Wound haemorrhage Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- 235000012735 amaranth Nutrition 0.000 description 1
- 239000004178 amaranth Substances 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 229940127003 anti-diabetic drug Drugs 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 230000002058 anti-hyperglycaemic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- TYPSVDGIQAOBAD-UHFFFAOYSA-N atractylone Natural products C1C2(C)CCCC(=C)C2CC2=C1OC=C2C TYPSVDGIQAOBAD-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
- 150000004283 biguanides Chemical class 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 229940097217 cardiac glycoside Drugs 0.000 description 1
- 239000002368 cardiac glycoside Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- PSJVJZYSECBFHJ-BANYBNOTSA-N convallamarin Chemical compound O([C@@H]1[C@@H](C)O[C@H]([C@@H]([C@@H]1O)O)O[C@@H]1C[C@@H](C[C@H]2CC[C@H]3[C@@H]4C[C@H]5[C@@H]([C@]4(CC[C@@H]3[C@]21C)C)[C@@H]([C@@](O5)(O)CCC(=C)CO[C@H]1[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O1)O)C)O[C@H]1[C@@H]([C@H](O)[C@@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@@H](C)O1)O)[C@@H]1O[C@H](C)[C@H](O)[C@@H](O)[C@H]1O PSJVJZYSECBFHJ-BANYBNOTSA-N 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 201000010064 diabetes insipidus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000034653 disorder of pilosebaceous unit Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- FWKBXSPDFCAHFN-DEOSSOPVSA-N dracorubin Chemical compound C1([C@H]2OC=3C=4C=5C=C(OC6=CC(=O)C(C)=C(C=56)OC=4C=C(C=3CC2)OC)C=2C=CC=CC=2)=CC=CC=C1 FWKBXSPDFCAHFN-DEOSSOPVSA-N 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000004345 fruit ripening Effects 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 239000007887 hard shell capsule Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- JQNVCUBPURTQPQ-XDWLXSIGSA-N inokosterone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(CO)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 JQNVCUBPURTQPQ-XDWLXSIGSA-N 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempherol Natural products C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 230000004140 ketosis Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229940074869 marquis Drugs 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 229930185276 moracenin Natural products 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- OELFLUMRDSZNSF-BRWVUGGUSA-N nateglinide Chemical compound C1C[C@@H](C(C)C)CC[C@@H]1C(=O)N[C@@H](C(O)=O)CC1=CC=CC=C1 OELFLUMRDSZNSF-BRWVUGGUSA-N 0.000 description 1
- 229960000698 nateglinide Drugs 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- LPMXVESGRSUGHW-HBYQJFLCSA-N ouabain Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1C[C@@]2(O)CC[C@H]3[C@@]4(O)CC[C@H](C=5COC(=O)C=5)[C@@]4(C)C[C@@H](O)[C@@H]3[C@@]2(CO)[C@H](O)C1 LPMXVESGRSUGHW-HBYQJFLCSA-N 0.000 description 1
- KKAHGGJBKUXDNQ-KRWDZBQOSA-N panaxynol Natural products CCCCCCCC=CC=CCC#C[C@@H](O)C=C KKAHGGJBKUXDNQ-KRWDZBQOSA-N 0.000 description 1
- 239000004025 pancreas hormone Substances 0.000 description 1
- 229940032957 pancreatic hormone Drugs 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- VBUNOIXRZNJNAD-UHFFFAOYSA-N ponazuril Chemical compound CC1=CC(N2C(N(C)C(=O)NC2=O)=O)=CC=C1OC1=CC=C(S(=O)(=O)C(F)(F)F)C=C1 VBUNOIXRZNJNAD-UHFFFAOYSA-N 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 239000009286 sanguis draxonis Substances 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 229930002534 steroid glycoside Natural products 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000009923 sugaring Methods 0.000 description 1
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- SGEWCQFRYRRZDC-VPRICQMDSA-N vitexin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O SGEWCQFRYRRZDC-VPRICQMDSA-N 0.000 description 1
- PZKISQRTNNHUGF-UHFFFAOYSA-N vitexine Natural products OC1C(O)C(O)C(CO)OC1OC1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O PZKISQRTNNHUGF-UHFFFAOYSA-N 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明涉及中医药领域一种治疗糖尿病的中药制剂,技术方案:人参5份、黄芪15份、白术15份、玉竹15份、桑白皮15份、川牛膝15份、血竭10份、甘草10份;将黄芪、白术、玉竹、桑白皮、川牛膝、甘草6味置多功能提取器中加水提取有效成分,滤取提取液并浓缩成浸膏;人参与血竭打成细粉,与黄芪、白术、玉竹、桑白皮、川牛膝、甘草6味的水提取液浸膏,加适量糊精等辅料制成胶囊剂或颗粒剂、水丸剂、实心丸剂等中药剂型,分装,即得;供症属肺热津伤、胃热积盛、肾阴亏虚、阴阳两虚之消渴症(即糖尿病)患者治疗,有清热润肺、清胃泻火、温阳滋肾固摄的功效;能降低血糖、血脂,改善糖尿病症状。
Description
1.所属领域
本发明涉及-种用中药配制成具有对糖尿病治疗作用的中药制剂。本配方适于制成颗粒剂,同时也适于制成胶囊剂、实心丸剂、散剂等,属中医药制剂领域。
2.背景技术
糖尿病(Diabetes mellitus):糖代谢疾病,由于缺乏令胰腺激素---胰岛素,体内的糖不能氧化产生能量,糖的蓄积导致糖在血中出现(高血糖症)和随后在尿中出现,症状包括:口渴,体重减轻,大量排尿,由于转而利用脂肪作为能量来源,导致酸碱平衡紊乱,血中酮体蓄积(酮症),最终发生抽搐以致糖尿病性昏迷,并发肺部感染、尿道感染、化脓性感染等多种疾病难于根治。
2.1糖尿病现代医学简述
糖尿病(Diabetes mellitus)是-组常见的代谢内分泌病,ADA/WHO分为四个类型:I型糖尿病(β细胞毁坏,常导致胰岛素绝对不足);II型糖尿病,胰岛素抵抗或胰岛素分泌障碍;特殊型糖尿病;妊娠糖尿病(gestional diabetes GDM).糖尿病早期在临床上无症状,至症状期才有多食、多饮、多尿、烦渴、善饥、消瘦或肥胖、疲乏无力等症状。久病者常伴发心脑血管、肾、肝及神经等病变。严重病例或应激时可发生酮症酸中毒,高渗昏迷、乳酸性酸中毒而威胁生命,常易并发化脓性感染、尿道感染、肺结核等。据卫生部门统计中国现有糖尿病患者约9000万人,而且增长迅速,很快过1亿即每13人中有1个糖尿病人,可怕!
2.2现代医学对糖尿病的防治
(1)宣传教育:教育是控制糖尿病早期的关键,教育内容包括已确诊的患者,了解糖尿病并逐渐熟悉饮食、运动、用药和尿糖、血糖监测等基本措施的综合治疗原则,配合医务人员提高控制质量。
(2)饮食治疗:适当节制饮食,可减轻细胞负担,尤其是血浆胰岛素空腹时及餐后不抵者,往往为治疗本病的重要疗法。根据体重、工作性质、节制食物中糖、蛋白质、脂肪分化比例、并随时调整。
(3)运动锻炼:
可以进行运动锻炼的患者参加适当的文娱活动,体育运动,体力劳动,可促进糖的利用,减轻胰岛素负担为本病有效疗法之-。
(4)药物治疗:近年来抗糖尿病药物有迅速的发展,目前用于临床的有降糖药物,磺酰脲类(Sulkonglurea),抗高血糖药物双胍类(Biguanide),α-葡糖苷酶抑制剂(α-glucosidase inhibitor),胰岛素增敏剂噻唑烷=酮(Thasolidinedionce),胰岛素促分泌剂非磺酰类如那格列奈(nateglilide)等;胰岛素可以防止急性并发症,糖症代谢紊乱,改善营养,防止各种感染等;如采用胰岛素强化治疗控制高血糖症,对防治慢性并发症有肯定的效果。
2.3糖尿病中医学论述
在古代中医并无“糖尿病”的论述,现代中医学将“糖尿病”归类于中医内科杂病之“消渴”症类。
消渴是以多饮、多食、多尿、身体消瘦或尿浊、尿有甜味为特征的病症。本症由于素体阴虚,复因饮食无节,情志失调,劳欲过度致肺燥、胃热、肾虚而作。病机之安为燥热偏盛、阴津亏耗、而以阴虚为本,燥热为标。若拖延日久,阴损及阳,可致气阴两伤或阴阳俱虚。临床上很据三多症状的主次把本症分为上、中、下三消,并以三消为辩证的标志。
上消:肺热津伤,临床表现:烦渴多饮、口干舌燥、尿频多量、舌边尖红、苔薄黄,脉洪数。
中消:胃热炽盛,临床表现:多食易饥、形体消瘦、大便干燥、苔黄、脉滑实有力。
下消:1.肾阴亏虚,临床表现:尿频量多、浑浊如脂膏、或尿甜、口干唇燥、舌红、脉沉细数。2.阴阳两虚,临床表现:小便频数、浑浊如膏、甚至饮-溲-、面色黧黑、耳轮焦干、腰膝瘦软、形寒畏冷、阳痿不举、舌淡苔白、脉沉细无力。
治疗原则:无论上、中、下消,均应立足滋肾养阴为主,清热润燥为辅,在此基础上可适当佐以益气、温阳、活血化瘀。消渴后期常并发雀目耳聋,疮疡痈疽、泄泻、水肿、中风等症,必须分症专治、病情严重积极救治。
2.4参考文献
(1).陈灏珠等上海复旦大学医学院编《实用内科学》ISBN7-117-04313-X/R.4314人民卫生出版社2002年4月第11版第十四篇新陈代谢疾病等。
(2).周文泉等中国中医研究院编《新编中医临床手册》ISBN7-80022-555-0金盾出版社1993年9月第-版。
(3).鲁兆麟等点校《神农本草经》巍·吴晋等述,清.孙星衍辑ISBN7-5381-2560-4辽宁医科技术出版社1997年8月第-版。
(4).牛占兵编著中医经典通缉《黄帝内经》ISBN7-5375-1518-8/R-297河北科技出版社1994年3月第-版。
(5).清-吴谦等编《医宗金鉴》ISBN7-117-00728-1/R.729人民卫生出版社1995年4月第二版
(6).郑占虎等编《中药现代研究与应用》ISBN7-5077-1318-0学苑出版社1998年1月第一版。
(7).谢宗万主编《全国中草药汇编》ISBN7-117-02380-5/8.285,人民卫生出版社1996年10月第二版。
(8).丁兆梦主编《中药药效与临床》ISBN7-5067-1925-8/R.285,中国医药科技出版社1999年2月第-版。
3.发明内容:
3.1辩证立论
糖尿病即中医之消渴之症,临床上早期即上消“肺热津伤”在临床上不易被重视,而没有积极治疗就到了有症状“胃热炽盛”的中期,由于糖尿病发展缓慢,重视不足。所以会自然而然进入下消症期:肾阴亏虚“阴阳两虚”的程度。故而本发明组方立足于通用之成药制剂的通用性而立法组方。对上消“肺热津伤”,中消“胃热炽盛”,下消“肾阴亏虚至阴阳两虚”,之论均有适宜之效。证侯与立法如下表述:
“肺热津伤”:立法治疗:清热润肺,生津止渴。用药白术、玉竹有健脾益气,燥湿利水、养阴润燥,生津止渴之功以御之。
“胃热积盛”立法治疗:清胃泻火,养阴增液。用药桑白皮、川牛漆有泻肺平喘、利水消肿,逐瘀通经,利水通淋之功以御之。
“肾阴亏虚,阴阳两虚”:立法治疗:滋阴固肾,温阳滋肾固摄。用药:人参、黄芪有大补元气、扶正固表、滋肾养肝之功,御之体虚欲脱、气虚乏力。
另外,对糖尿病并发之疮痈肤溃、治痞瘕疵之症,佐以血渴血活化淤、敛口生肌,等等。
3.2处方组成
人参5份、黄芪15份、白术15份、玉竹15份、桑白皮15份、川牛膝15份、血竭10份、甘草10份共8味,每味份量误差应在±5%范围内,将以上8味制成制成胶丸剂或颗粒剂、水丸剂等。
功能主治:润肺生津,清胃养阴,温阳滋肾。用于证属肺热津伤、胃热积盛、阴阳两虚等消渴症范围糖尿病、尿崩症等病以及疮疡、泄泻等并发症助其收敛排脓生肌。
用法与用量:每日服用3次,每次服用量相当于生药15g,连续服用1周以上。
收率与辅料量的计算:按每次服用量相当生药量15g计,各味药材量为人参0.75g、黄芪2.25g、白术2.25g、玉竹2.25g、桑白皮2.25g、川牛膝2.25g、血竭1.5g、甘草1.5g;其中人参、血竭直接打粉,收率约95%,即得药材粉2.25g,黄芪、白术、玉竹、桑白皮、川牛膝、甘草6味水煮提浓缩浸膏,收率约9%,即得浸膏12.75g×0.9%=1.15g;上述药材粉与浸膏共为3.4g;辅料为糊精按斌形剂基本占约30%才能成功剂型,即约1.6g,最终每次服用量5g(如颗粒剂或实心丸剂)。
3.3关键性技术
3.3.1组方合理。
凡中医药组方,讲究君臣佐使配方的主次程序章法,本发明组方方解如下:
以人参、黄芪共为君药,此二味均为补益扶正固本药。
以白术、玉竹共为臣药,此二药均可归胃径,着力于清胃之功。
以桑白皮,川牛膝二味助佐,适于清肺热,逐瘀瘕痞痈疽功效。
以血竭、甘草为使药,血竭活血,生新生肌,甘草清热解毒,调和诸药。
总之,本组方中以人参黄芪大补之药,大补糖尿病之肾阴亏虚,阴阳两虚,以固本培元;白术、玉竹清内热,利水道、解消渴;桑白皮、川牛膝则消肿逐瘀、利尿通淋、利关节;血竭对糖尿病之最常见并发症皮肤溃破之症有特殊的活血化瘀、而更增效利于桑白皮、川牛膝逐瘀、祛瘀的抑菌、敛口、生肌、甘草则缓解人参黄芪之烈补……所以认为用药独特,组方合理、对糖尿病的治疗缓解高血糖、高血脂进展有确切的作用。
3.3.2用药独到
针对糖尿病主要并发皮肤破溃疮疡、久治不愈、诸多“西医”束手无策之症,本组方前所未有地选用活血之圣药血竭、具有较好的活血止痛、散瘀生新、止血生肌功效。且现代科技证实具有较好的抗菌抗病毒作用,使其较好的收敛疮口,生肌,愈合。这在对糖尿病并发症治疗中尚无文献记录本发明开先河用之效果独到。
3.3.3制备工艺独特
针对人参药材价值较高、杂质较少,及血竭纯度较高且不易溶于水的性质,采用其干燥粉碎成细分使用,全粉末入药的工艺,-则药物损失少,二则避免高温提取加工过程破坏损失有效成分,使药物功效更佳。
3.4制备工艺规程
(1)将各味药材分别进行检拣、弃除杂质等;
(2)将人参切片,烘干打成细粉;
(3)将血竭打成碎块、烘干打成细粉;
(4)将黄芪、白术、玉竹、桑白皮、川牛膝、甘草进行切片,混合。移置多功能提取器中加10倍量水,常压煮提60min×2,过滤、收集滤液,第二次加约6倍量水,常压煮提60min×1.5过滤,收集滤液;第三次加约4倍量水,常压煮提60min×1.0,滤过,三次滤液混合,浓缩成浸膏(此重约1.15g/ml)
(5)将红参粉、血竭粉、药材浸膏与适量糊精混合,制粒、烘干。
(6)将干燥颗粒装填入胶囊壳中、包装,即得胶囊剂、注:制成颗粒剂或实心丸剂等仅有辅料添加量的增减区别。
3.5本发明有益效果
糖尿病临床上病机主要为燥热偏盛,阴津亏耗,迁延日久,阴阳两虚;本发明组方以补益滋肾养阴为主,清热润燥为辅,人参、黄芪大补元气,白术、玉竹、桑白皮清热润燥,川牛漆、血竭逐瘀生肌。能较好调节糖尿病之糖多、食多、尿多、尿浊尿甜及水肿等症状。
(1)本组方用血竭主要能对糖尿病之痈疽、癓瘕皮肤溃疡等,活血化瘀,生津,收敛,生肌的独特功用。
(2)本组方中经现代医药学测试验证,黄芪,桑白、白术、玉竹四味均有-定的降血糖、降血脂作用,直接对糖尿病血糖、血脂进行控制而达到治疗目的。
(3)本组方中桑白等、川牛漆有-定的降血压作用,对糖尿病并发症有-定治疗作用。
(4)本组方中白术对糖尿病并发症泄泻有治疗作用
(5)本组方中8味药材除血竭外均为“即是食品又是药品”及“可用于保健食品”的中药材,按规定食品或保健食品配方中充许1味非上述范围药材。注:中国卫生部2002年2月28日“关于进一步规范保健食品原料管理的通知”。按卫生部及国家药品管理局的相关药品、保健食品、食品生产注册批准文号的规定,本组方可按食品申报生产,也可按保健食品生产,不需要做临床验证等,程序少很多,费用低很多,时间短很多,回报快很多。
本发明组方所用原料辅料均有国家标准,药材药效文献记载确切可靠,组方配制合理,制备工艺技术科学先进,可以批量生产,可用科技手段监控产品质量,保证安全有效,宜大面积推广为成药使用造福更多糖尿病患者。
(6)本发明组方与制备方法所得产品利于贮藏、便于运输,携带使用方便,有良好的社会效益。
3.6配方中药材性味功能与临床用途
人参:本品为五加科植物人参Panax ginseng C.A.Mey的干燥根。本组方用红参。中国药典2010年版-部8页。主要化学成分:人参皂甙,人参炔醇油,有机酸及脂、甾醇及其甙,多肽、蛋白质、多种维生素及多种微量元素等。性味与归经:甘,微苦,平。归脾、肺、心径。大补元气,用于体虚欲脱,肢冷脉微,脾虚食少,肺虚喘咳,津伤口渴,内热消渴。
黄芪:本品为豆科植物蒙古黄芪Astragalus menbranacus Bge.Var.Mongholicus(Bge.)Hscao或膜荚黄芪Astragalus menbranaceus(Ficsh.)Bye,的干燥根。气微,味微甜,嚼之微有豆腥味。中国药典2010年版-部283页,主要化学成分:三萜皂甙,黄酮类,氨基酸,多醣类,硒、锌等微量元素;性味与归经:甘,温。归肺、脾径。扶正之药,用于气虚,乏力,食少便溏。
按照“滋肾养阴为主,清热润燥为辅”的治疗原则,本方中二味补益之药,人参功能“大补元气,复脉固原,补脾益肺,生津安神:但有较大热燥而分量占方中5%,黄芪功能“补气固表,利尿托毒,排脓敛疮生肌”,适于脾胃亏虚,中气下陷,卫气阴虚,血气不足,对改善糖尿病症状有较好的作用。黄芪有校好的降血糖降血脂的作用(郑占虎等主编《中药现代研究与应用》ISBN7-5077-1318-0,学苑出版社1998年1月第-版第3919页等文献)。
白术:本品为菊科植物白术Atractylodes macrocephala Koidz.的干燥根茎,气清香,味甘,微辛,嚼之略带粘性,中国药典2010年版-部95页。主要化学成分:苍术酮、苍术醇等挥发油,炔基化合物多种,果糖,菊糖,白术多糖,丝氨酸及谷氨酸等多种氨基酸,维生素A等。性味归径:苦,甘、温。归脾、胃径。功能与主治:健脾益气、燥湿利水,止汗,安胎。用于脾虚食少,腹胀泄泻,痰饮眩悸,水肿,自汗等。
玉竹:本品为百合科植物玉竹Polygonatum odoratum(Mill)Druce的干燥根茎,气微,味甘,嚼之发粘。中国药典2010年版-部78页。主要化学成分:铃兰苦甙,铃兰甙等甾体皂甙,β-谷甾醇,黄酮类,山奈酚甙,解皮素甙,黄精素,牡荆素等,多糖,维生素及K.P.Mn,Si.Ca.Ma等矿物质。性味与归径:甘,微寒。归肺,胃径。功能与主治:养阴润燥,生津止渴。用于肺胃阴伤,燥热咳嗽,咽干口渴,内热消渴。
白术补气,玉竹补阴,二者均可归胃径,清胃组合强化,清内热、利水、解消渴,白术对糖尿病并发症之泄泻有治疗作用,据郑占虎等主编《中药现代研究与应用》ISNB7-5077-1318-0,字苑出版社1998年1月第-版第1246页:白术和玉竹均有较好的降血糖降血脂作用,白术与玉竹配伍臣药最佳选择。
桑白皮:本品为桑科植物桑Morusalbal的干燥根皮,气微,味微甘。中国药典2010年版-部280页。含主要化学成分:桑白皮素等黄酮类、香豆精衍生物,桦树酸等三萜类,多糖、挥发油、鞣质、桑皮醇、粘液素等。桑白皮性味:甘、寒、归肺径;功效泻肺平喘,利水消肿、用于肺热喘咳、水肿胀满,尿少,面目肌肤浮肿,另外尚有-定的降血压作用。桑白皮与枸杞子水煎服治糖尿病(注:丁兆梦编著《中药药效与临床》ISBN7-5067-1925-8,中国医药科技出版社1999年2月第-版第53页),桑白皮有效成分有降血糖作用,对人体能促进蛋白质合成,排出体内胆固醇,降低血脂(注:郑占虎主编《中药现代研究院与应用》ISBN7-5077-1318-0字苑出版社1998年1月第-版3870页。
川牛膝:本品为苋菜科植物川牛膝Cythula officinalis kuan的干燥根,气微,味甜,中国药典2010年第-部35页,含主要化学成分:三萜皂甙,牛膝甾酮、多糖、氨基酸、Se、Mo、等微量元素。性味甘,微苦,平,归肝,肾径,功效逐瘀通经,通利关节、利尿通淋、主治:腰膝酸痛、筋骨无力、经闭癓瘕,肝阳眩晕等,牛膝有-定的镇痛、利尿、降血压作用,牛膝既能补肾又能通血脉利关节,利尿、行瘀通淋(丁兆梦编著《中药药效与临床》ISBN7-5067-1925-8中国医药科技出版社1999年2月第-版179页)。
血竭:本品为棕科常绿膝本植物麒麟竭Daemonoreps draceBL.的果实成熟时分泌出的红色树脂、中国药典2010年版-部133页。血竭性味甘、咸、平、入心、肝径。功效活血止痛、散瘀生新、止血生肌、用于跌打损伤、瘀血作痛、心腹卒痛、金疮出血、疮疡不敛等。经卫生部组织验证(临床),在“活血化瘀”等方面国产血竭与进口血竭功效相同,本发明组方选用海南、云南、广西等地的龙血树血竭,原植物为龙舌兰科(百合科)龙血树属植物剑叶龙血树Daemona Cochinchinensis(Lour)S.Cchen或海南龙血树Daemona Cambodiana Piere的红色树脂,常称国产血竭,主要化学成分为多糖、强心甙,黄酮、挥发油及酚类成分,文献:《中国药房》ISSN1001-040——1992年1期(总第13期)45-46页,曾正·《国产血竭研究近况》。国产血竭虽不含血竭红素等化学成分,而其“活血化瘀及对黄色葡萄球菌、白喉杆菌、皮肤真菌等的抑制作用强于进口血竭,进口血竭来源多品种植物,加工辅料物杂乱,难于保证质量,故而用国产血竭,其活血化瘀及抑菌敛口生肌之功。对糖尿病并发症皮肤破溃等逐瘀抑菌敛口生肌。文献:谢宗万主编《全国中医草药汇编》下册ISBN7-117-02379-1人民卫生出版1996年10月第二版254-257页。郑占虎主编《中药现代研究与应用》ISBN7-5077-1316-4学苑出版社1997年10月出版第1992-1930页,关于“国产血竭替代进口血竭的研究”等章节文献。
甘草:本品为豆科植物甘草Glycyrrhiza uralensis Fisch胀果甘草Glycyrrhizainflate Bat或光果甘草Glycyrrhiza glabra L的干燥根及根茎,气微,味甜而特殊。中国药典2010年版-部80页。主要含化学成分:三萜皂甙。黄酮类甘草酸、其钾钠盐为甘草甜素,黄酮类,生物碱、香豆素及硒等微量元素。性味与归径:甘,平,归心肺、脾、胃径。功能与主治:补脾益气,清热解毒,祛痰止咳,缓急止痛,调和诸药。在本组方中,人参、黄芪补元凶猛性烈。使之甘草、调和缓之。
以上8味中药各有补益扶正,固本培元,降血糖,降血压,利尿通淋,逐瘀生机,敛口生新,清热解毒之所长,组方整合,增效强功,对糖尿病及其并发症如泄泻、高血压、中风、皮肤破溃等有较好的治疗作用。
4.具体实施方式
4.1本发明配方
人参5份、黄芪15份、白术15份、玉竹15份、桑白皮15份、川牛膝15份、血竭10份、甘草10份,共8味,每味份量误差应在±5%范围内。
4.2制备工艺规程
(1)将各味药材分别进行检拣、弃除杂质等;
(2)将人参切片,烘干打成细粉;
(3)将血竭打成碎块、烘干打成细粉;
(4)将黄芪、白术、玉竹、桑白皮、川牛膝、甘草进行切片,混合,移置多功能提取器中加10倍量水,常压煮提60minX2,过滤、收集滤液,第二次加约6倍量水,常压煮提60minX1.5过滤,收集滤液;第三次加约4倍量水,常压煮提60minX1.0,滤过,三次滤液混合,浓缩成浸膏(此重约1.15g/ml)
(5)将红参粉、血竭粉、药材浸膏与适量糊精混合,制粒、烘干。
(6)将干燥颗粒装填入胶囊壳中、包装,即得胶丸剂、注:制成颗粒剂或实心丸剂等仅有辅料添加量的增减区别。
4.3临床应用情况
本方剂于上世纪八十年代初,发明人-位亲友被查出糖尿病,当时患者45岁,普通职工,医疗条件-般,但当时尚在改革开放初期,很多先进的化学降糖药均只有国外欧美发达国家才有,患者生命受到自身疾病威胁。发明人作为-位医药专业技术人员,看在眼里,急在心里,于是查阅收集了大量相关资料,组方中药煎剂给与患者服用。料不到的是结果患者病情稳定……而后健康生活21年。之后又陆续给十多位糖尿病患者服用(水煎服),坚持服用者效果理想。可以说是-组经验方,在这基础上,发明人5年前退休后认真总结,组方与临床效果情况、改进制备工艺,制成胶丸剂(硬胶囊剂),进行临床初步试用观察。
病例条件:经县级以上医院(西医)诊为“糖尿病”或高血糖高血脂病例。
药物制剂:用本发明配方,制备成胶丸剂(硬胶囊),每粒含生药相当于4g,每次4粒(相当于生药15g/次),连续服-个月后复查。
病例情况:糖尿病共39例(注:条件限制,并非同时受试,而是争求到已确诊病例自愿先后陆续进行受试),其中男19例,女20例,年龄最大64岁,最小37岁,病程最长10年,最短1个月(当被诊为糖尿病的即接受本发明药物受试治疗);另有9例为首次体检发现血糖高血脂高而无其它症状者,也同样服用本发明胶丸制剂1个月,共48例受试者。
用药结果:
(1)7例体检被血验为“高血糖、高血脂”者,经复查,5例血糖血脂降低到合格范围,2例有大幅度降低,说明对降血糖有较明显的作用。
(2)被诊为“糖尿病”患者39例中有33例用本发明组方颗粒剂30天后复查,血糖血脂均有明显降低,其他症状也有改善,6例没有进行复查,但感觉“舒服多了”“状况好多了”其中5例有皮肤破溃者,收敛很好,疼痛减轻,有生新肉样,所有试用者表示还要求继续服用。
总之,从临床试用结果看,本发明组方制剂对糖尿病的治疗有降低血糖血脂的作用,有修复脾肾能力,对疮疡痈疽敛口生肌有良好的作用。由于临床病例受试较少,临床资料不多,无统计学意义,但所有受试者均100%有效,所以希望申请专利保护进-步开发,研究提高使能更好地服务于社会。
4.4具体实施范例
4.4.1胶囊剂制备处方:人参50kg、黄芪150kg、白术150kg、玉竹150kg、桑白皮150kg、川牛膝150kg、血竭100kg、甘草100kg,共8味1000kg。
制备工艺:
(1)将人参切片,烘干,打成细粉;
(2)将血竭打成碎块,烘干,打成细粉;
(3)将黄芪、白术、玉竹、桑白皮、川牛膝、血竭、甘草共6味切片,混合,置多功能提取器中加水常压提取3次,混合滤液,浓缩成膏;
(4)将人参粉、血竭粉及适量辅料(糊精约0.6g)加入药材浸膏中,混匀,制成小颗粒,烘干,装填入空胶囊壳中,每粒1g,分装,得胶囊剂。
用法用量:口服,每日服3次,每次4粒(服用量相当于生药材量约15g),连续服用1周以上。
4.4.2颗粒剂制备处方:人参50kg、黄芪150kg、白术150kg、玉竹150kg、桑白皮150kg、川牛膝150kg、血竭100kg、甘草100kg,共8味1000kg。
制备工艺:
(1)将人参切片,烘干,打成细粉;
(2)将血竭打成碎块,烘干,打成细粉;
(3)将黄芪、白术、玉竹、桑白皮、川牛膝、血竭、甘草共6味切片,混合,置多功能提取器中加水常压提取3次,混合滤液,浓缩成膏;
(4)将人参粉、血竭粉及适量辅料(糊精约1.6g)加入药材浸膏中,混匀,制成小颗粒(无糖颗粒剂),烘干,分装,每小袋5g(相当于生药量15g),得颗粒剂。
用法用量:用热水冲化,口服,每日服3次,每次1袋,连续服用1周以上。
4.4.3实心丸剂制备处方:人参50kg、黄芪150kg、白术150kg、玉竹150kg、桑白皮150kg、川牛膝150kg、血竭100kg、甘草100kg,共8味1000kg。
制备工艺:
(1)将人参切片,烘干,打成细粉;
(2)将血竭打成碎块,烘干,打成细粉;
(3)将黄芪、白术、玉竹、桑白皮、川牛膝、血竭、甘草共6味切片,混合,置多功能提取器中加水常压提取3次,混合滤液,浓缩成膏;
(4)将人参粉、血竭粉及适量辅料(糊精约0.6g)加入药材浸膏中,混匀,制成软材,将混匀之软材上制丸机生产联动线,经制软材、制丸、整丸、选丸、干燥、上衣、干燥而制成“实心丸”,分装,即得;
用法用量:口服,每次服用量4g(相当于生药材15g),每日服用3次,连续服用1周以上。
特别说明:
(1)因糖尿病人“忌糖”,所以在制剂辅料中尽可能不加糖。
(2)本组方制剂较为适宜胶囊剂、无糖颗粒剂、实心丸剂、也可制成片剂、散剂、水蜜丸剂、水泛丸剂等。
Claims (1)
1.一种治疗糖尿病的中药胶囊,其特征在于:人参5份、黄芪15份、白术15份、玉竹15份、桑白皮15份、川牛膝15份、血竭10份、甘草10份;将人参、血竭打成细粉备用,黄芪、白术、玉竹、桑白皮、川牛膝、甘草6味置多功能提取器中加水提取有效成分,滤取提取液并浓缩成浸膏,加入人参和血竭粉及适量糊精,混合均匀,制成颗粒,干燥,装填于胶囊壳,即得能降低血糖、血脂,改善糖尿病症状的中药胶囊剂。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310019988.1A CN103933282B (zh) | 2013-01-18 | 2013-01-18 | 一种治疗糖尿病的中药胶囊 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310019988.1A CN103933282B (zh) | 2013-01-18 | 2013-01-18 | 一种治疗糖尿病的中药胶囊 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103933282A CN103933282A (zh) | 2014-07-23 |
| CN103933282B true CN103933282B (zh) | 2017-08-01 |
Family
ID=51181339
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310019988.1A Expired - Fee Related CN103933282B (zh) | 2013-01-18 | 2013-01-18 | 一种治疗糖尿病的中药胶囊 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103933282B (zh) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105770715A (zh) * | 2014-12-19 | 2016-07-20 | 北京宝德润生医药科技发展有限公司 | 一种具有降血糖功能的组合物及其制备方法 |
| CN105663439A (zh) * | 2016-01-15 | 2016-06-15 | 宁夏医科大学 | 一种用于预防和治疗糖尿病的药物组合物及其制备方法 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101167846A (zh) * | 2007-10-26 | 2008-04-30 | 刘会东 | 一种具有降糖作用的胶囊及其制备方法 |
| CN102218116A (zh) * | 2010-05-10 | 2011-10-19 | 北京华仁堂药物科技有限公司 | 治疗糖尿病的中药药物及其制备方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103263580A (zh) * | 2013-04-29 | 2013-08-28 | 青岛市市立医院 | 一种治疗糖尿病的中药组合物 |
-
2013
- 2013-01-18 CN CN201310019988.1A patent/CN103933282B/zh not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101167846A (zh) * | 2007-10-26 | 2008-04-30 | 刘会东 | 一种具有降糖作用的胶囊及其制备方法 |
| CN102218116A (zh) * | 2010-05-10 | 2011-10-19 | 北京华仁堂药物科技有限公司 | 治疗糖尿病的中药药物及其制备方法 |
Non-Patent Citations (2)
| Title |
|---|
| 施今墨学派名老中医诊治糖尿病学术思想与经验传承研究;庞博;《中国博士学位论文全文数据库(电子期刊)》;20121215(第12期);第144页"2.1治法分布",第150-154页"2.12用药分布"表18 * |
| 血竭临床应用概述;朱青,等。;《山东中医杂志》;20060605;第25卷(第6期);第429页右栏2.2"治疗糖尿病及并发症"。 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103933282A (zh) | 2014-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104435775B (zh) | 一种中药保健酒及其制备方法 | |
| CN102048933A (zh) | 一种治疗小儿腹泻的中药组合物及其制备方法 | |
| CN108295211A (zh) | 一种治疗糖尿病的药食同源食品组方及其制备方法 | |
| CN108524814A (zh) | 一种用于降低血糖的中药组合物及其制备方法 | |
| CN103933282B (zh) | 一种治疗糖尿病的中药胶囊 | |
| CN104857238A (zh) | 一种治疗脾肾阳虚型缺铁性贫血的中药及制备方法 | |
| CN101095798B (zh) | 一种治疗白发病的中药药物 | |
| CN117599125B (zh) | 一种用于治疗骨质疏松症的补钙壮骨中药组合物及制法和应用 | |
| CN105796845A (zh) | 药物组合物在制备治疗女性更年期综合征药物中的用途 | |
| CN104825821A (zh) | 一种治疗糖尿病的药物及其制备方法 | |
| CN105311470A (zh) | 含有艾叶的药物组合物用于制备治疗糖尿病肾病药物中的用途 | |
| CN104258359A (zh) | 一种用于治疗妊娠反应的中药组合物及其制剂的制备方法 | |
| CN109528968A (zh) | 一种治疗2型糖尿病的中药组合物及其制备方法和应用 | |
| CN101884760B (zh) | 一种治疗糖尿病的中药组合物及其制备方法 | |
| CN108186966A (zh) | 一种预防或改善老年痴呆症的组合物及其应用 | |
| CN102552743A (zh) | 一种用于治疗糖尿病的药物组合物及其制备方法 | |
| CN106138785A (zh) | 一种治疗神经衰弱的中药组合物及其制备方法 | |
| CN105343675A (zh) | 一种治疗肥胖症的中药制剂及其制备方法 | |
| CN104258224A (zh) | 一种治疗肺肾阴虚型慢性支气管炎的五味子口服液及其制备方法 | |
| CN105796755A (zh) | 一种治疗糖尿病肾病的中药组合物 | |
| CN110840996A (zh) | 一种治疗气阴两虚代谢综合征的中药配方、方法、制剂及用途 | |
| CN101164595A (zh) | 一种治疗厌食症的中药 | |
| CN102302691A (zh) | 一种消除病人术后不适症的药茶饮及其制备方法 | |
| CN108310212A (zh) | 一种用于延缓衰老的药物及其制备方法和应用 | |
| CN107854562A (zh) | 一种补肾壮阳的中药组方 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20170801 Termination date: 20190118 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |